Delivery Order SPE2DB24D2205-SPE2DB25FEDUA
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,485.96 by the Defense Logistics Agency for the supply of Zilretta 32 mg vials. The award, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,287.25 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, for the supply of Zilretta 32 mg vials. The competitively awarded, firm fixed-price contract carries an ultimate completion date of September 8, 2025, and involves performance at the vendor's Conshohocken facility. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with a firm fixed price and no set-aside designation. The order, placed under a competitive award process, is scheduled for completion by September 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,714.90 on September 25, 2025, for the supply of Zilretta 32 mg vials, with performance completion targeted for October 17, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, valued at $1,485.96 with a firm fixed price structure. The contract, awarded on August 13, 2025, carries an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order falls...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a delivery order valued at $1,114.47 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, a specialized pharmaceutical product. This competitively awarded, firm fixed-price contract is scheduled for completion by September 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $7,429.80 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Zilretta 32 mg vials, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency valued at $3,714.90 for the supply of Zilretta 32 mg vials. This is a firm fixed-price, non-set-aside contract with a completion deadline of May 23, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen's broader federal pharmaceutical supply relationship...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDUADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,228.94 by the Defense Logistics Agency on June 16, 2025, for the supply of Zilretta 32 mg vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 9, 2025, and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The delivery order supports the Defense Logistics Agency's medical supply chain operations, which furnish pharmaceutical products and medical supplies to the Defense Health Agency, U.S. military healthcare systems, and other federal government customers. Zilretta is an intra-articular corticosteroid injection used for pain management in orthopedic applications. AmerisourceBergen's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates the company's capability to consistently meet federal medical procurement requirements through open competition, delivering a broad spectrum of pharmaceuticals ranging from specialty medications to generic drugs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/16/25 |